IBS drug can cause pancreatitis symptoms
Patients who took Viberzi® are just now speaking out against the extreme adverse effects as a result of taking the IBS-D drug.
Viberzi Legal Hotline
Call right now!
Do not stop using these drugs without first consulting with your physician.
Viberzi® Settlement Amounts, Compensation and Victim Payouts
Patients who had their gallbladder removed and later developed pancreatitis while taking Viberzi® may qualify for a free Viberzi® lawsuit investigation. A Viberzi® lawsuit would file against the Viberzi® manufacturers, to hold them accountable for not warning patients of the risks involved with the drug.
Plaintiffs could potentially recover compensation for medical expenses, pain and suffering, loss of wages, loss of earning capacity, and more through Viberzi® lawsuit settlements.
Multiple Viberzi® lawsuits are currently being filed against Allergan for failing to disclose a risk of serious and life-threatening side effects of Viberzi®, and settlement amounts for Viberzi® lawsuits are likely to be substantial.
IBS drug Viberzi®
Viberzi® is the brand name of the drug Eluxadoline. This medication is used to treat people suffering from diarrhea-predominant irritable bowel syndrome (IBS-D).
While the drug was approved by the U.S. Food and Drug Administration (FDA) in 2015, it has recently been linked with an increased risk of developing the serious, and sometimes deadly, condition pancreatitis.
This increased risk of pancreatitis is only for patients who have previously had their gallbladder removed.
Viberzi® is a registered trademark of Allergan Holdings Unlimited Company